PT  - JOURNAL ARTICLE
AU  - Burke, Cyril O.
AU  - Tanzer, Joshua Ray
AU  - Toffaletti, John G.
AU  - Burke, Leanne M.
TI  - Re-analyzed APOL1 kidney data support new ethics of ‘race’
AID  - 10.1101/2024.09.15.24313684
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.09.15.24313684
4099  - http://medrxiv.org/content/early/2024/11/17/2024.09.15.24313684.short
4100  - http://medrxiv.org/content/early/2024/11/17/2024.09.15.24313684.full
AB  - OBJECTIVES Research on ‘racial’ differences and racialized diseases often stresses genetics over social conditions, perhaps because some medical journals limit (or exclude) as social ‘Commentary’ discussion of ‘race’ as a proxy for social determinants of health. Yet, anthropology research shows ‘race’ is socially constructed, and from early childhood, persistent ‘racial’ segregation ‘racializes’ health, education, employment, and access.Because social deprivations contribute to ‘racial’ difference, we hypothesized that selective recruitment into US military service, equal opportunity for military training and jobs, and earned access to Veterans Administration Healthcare could offset childhood deprivations and social determinants of health linked to socially constructed ‘race’. Our research examined whether veteran status could mitigate the starkest ‘racial’ disparity in healthcare—kidney disease.METHODS Our research re-analyzed ‘racialized’ kidney data from US veterans. First, we defined terms to ensure cross-cultural clarity by orienting international colleagues to the semantics of socially constructed ‘race’ (in Europe) and overt and subtle ‘racialization’ of health (in the US). Second, we removed ‘race correction’ from estimated kidney function under more equal conditions. Third, we used data re-analysis and examination of social cofactors to suggest alternative mechanisms for links between socially constructed ‘race’, apolipoprotein L1 genetic variants, and ‘racialized’ kidney disease.RESULTS Under more equal social conditions, our research found no disparity in kidney failure by ‘race’, suggesting mitigation by Armed Services entry requirements, equitable military opportunities, and subsequent access to Veterans Administration Healthcare. We also found that geographically localized “ancestry markers” can proxy for ‘race’, and that ‘colorism’ may be one mechanism of action for apolipoprotein L1 variants.CONCLUSIONS Under equitable social conditions, comparable outcomes should be the expected norm for all, regardless of socially constructed ‘race’, ethnicity, or nationality. Disparity between socially constructed categories should be explored for unequal social conditions. International collaboration to discourage misuse of socially constructed ‘race’ in medical care and research is an actionable Population Health initiative with potentially high impact but low effort and cost.STRENGTHS OF THIS STUDYReminds readers of cross-cultural contradictions in socially constructed ‘race’.Introduces international observers to racialization of health in the US.Re-analyzes socially constructed ‘race’ under more equal conditions.Applies new ethics recommendations by the National Academies of Sciences, Engineering, and Medicine to older research on socially constructed ‘race’.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally published in the three source articles.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data re-analyzed in the present work are contained in the manuscript or are publicly available in the original source articles.AKIacute kidney injuryAPOL1apolipoprotein L1BSbad scienceCKDchronic kidney diseaseCOVIDcoronavirus diseaseeGFRestimated GFRFSGSfocal segmental glomerulosclerosisGFRglomerular filtration rateHRhigh riskLRlow riskIRBinstitutional review boardKFkidney failureMDRDModification of Diet in Renal DiseaseNASEMNational Academies of Sciences Engineering and MedicineORodds ratioRRrelative riskRVrisk variantSDOHsocial determinants of healthVAVeterans Administration